Skip to main content
. 2011 Feb 10;12:15. doi: 10.1186/1471-2172-12-15

Figure 3.

Figure 3

In-polyIC treatment induces effective antiviral protection. HT1080 cells were challenged with virus after various pre-treatments including extracellular and intracellular polyIC for 7 hours. IFNA2A treatment was a positive control to show that biologically significant interferon pre-treatment protects cells against virus. Fu-gene (transfection reagent) and 0.4 μg/ml of ex-polyIC were negative controls to show neither of them alone elicits anti-viral protection. Cell viability was measured with crystal violet staining that shows live cells in purple. A. HT1080 cells were challenged with a serial dilution (from MOI 1 to 0.001) of encephalomyocarditis virus (EMCV). B. Summary of Figure 3A. Amount of input EMCV virus (MOI) that causes 50% (or greater) cell survival across different polyIC treatments. C. HT1080 cells were challenged with a serial dilution (from MOI 1 to 0.001) of vesicular stomatitis virus (VSV). D. Summary of Figure 3C. Amount of input VSV virus (MOI) that causes 50% (or greater) cell survival across different polyIC treatments.